The remaining change reflects $1.2 million of increased compensation expense-related headcount, a $.3 million increase in independent agent commissions resulting from revenue mix, and a $.3 million increase in travel-related expenses partially offset by a $.9 million reduction in consulting fees.

Aug 11, 2026 / receipt, needs a key / Scott Neils, CFO | earnings call 2026-08-11 | transcript dfe6380e-6ca4-4a43-a410-133768f5e616 | chars 11812-12109 | segment 11

I think the way to think about this is, you know, as we mentioned, we're bringing on 21 employees. These, for the most part, are generally seasoned reps. So when you think about the compensation associated with such an individual, and then you would add to that travel and marketing expense to the tune of $1.5 million annually per you're probably looking at at least $2.5 million quarterly in way of additional sales and marketing expense.

May 13, 2026 / receipt, needs a key / Scott Neals, CFO | earnings call 2026-05-13 | transcript 3b665cbd-a003-4bf0-a0a6-8a9765ccda22 | chars 15829-16269 | segment 15

Aircraft N369FG, registered to FULGENT GENETICS INC, landed at KBZN (Bozeman Yellowstone International Airport) on 2026-08-21. KBZN is 1.2 miles from the headquarters of Xtant Medical Holdings Inc. in Belgrade, MT.

company_statement / Aug 21, 2026 / receipt